ClinicalTrials.Veeva

Menu
A

Arsema | Clinica Adventista Belgrano

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Nivolumab
BGE-175
Estrogen
Fostamatinib
Olpasiran
Exemestane
Tamoxifen
Letrozole
Anastrozole

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 6 total trials

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence (ELEGANT)

The primary goal of this study is to evaluate the effectiveness of elacestrant versus standard endocrine therapy in participants with node-positive,...

Enrolling
Breast Cancer
Drug: Elacestrant
Drug: Tamoxifen

The primary objective of this study is to compare the effect of treatment with olpasiran, to placebo, on the risk for coronary heart disease death (C...

Active, not recruiting
Atherosclerotic Cardiovascular Disease
Drug: Olpasiran
Drug: Placebo

Trial sponsors

Amgen logo
B
Bristol-Myers Squibb (BMS) logo
Rigel Pharmaceuticals logo
Stemline Therapeutics logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems